diagnostics

Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe
Ancestry launches consumer genetics tests for health, intensifying rivalry with 23andMe
Stat
diagnostics
Ancestry
23andMe
DNA testing
home genetic testing
Flag link:
A Blood Test for Brain Cancer with a Dash of AI Added
A Blood Test for Brain Cancer with a Dash of AI Added
Medical Devices and Diagnostics Industry
diagnostics
brain cancer
ClinSpec Diagnostics
artificial intelligence
Flag link:
Qiagen and Illumina in It for the Long Haul with 15-year Collaboration
Qiagen and Illumina in It for the Long Haul with 15-year Collaboration
Medical Devices and Diagnostics Industry
Qiagen
Illumina
diagnostics
oncology
Flag link:
Dana-Farber Study Confirms Accuracy of GRAIL's Blood Test for Cancer
Dana-Farber Study Confirms Accuracy of GRAIL's Blood Test for Cancer
BioSpace
diagnostics
Grail
Dana-Farber
cancer
Flag link:
Newly Cleared Blood Test Closes Gender Gap in Diagnosing Heart Attacks
Newly Cleared Blood Test Closes Gender Gap in Diagnosing Heart Attacks
BioSpace
Abbott Labs
FDA
diagnostics
heart attacks
gender gap
women
Flag link:
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Yahoo/Zacks.com
EXACT Sciences
Cologuard
diagnostics
colorectal cancer
Flag link:
OncoCyte Acquires Razor Genomics to Improve Management of Early-Stage Lung Cancer
OncoCyte Acquires Razor Genomics to Improve Management of Early-Stage Lung Cancer
BioSpace
OncoCyte
Razor Genomics
diagnostics
M&A
non-small cell lung cancer
Flag link:
Roche Packs New FDA-Approved Test in Its Arsenal
Roche Packs New FDA-Approved Test in Its Arsenal
Medical Devices and Diagnostics Industry
Roche
Babesia test
Babesia DNA
Babesia RNA
diagnostics
Flag link:
FDA approves GE’s AI-based collapsed lung detection system
FDA approves GE’s AI-based collapsed lung detection system
Pharmaforum
FDA
pneumothorax
diagnostics
devices
GE Health
Criticial Care Suite
artificial intelligence
Flag link:
More to come from PARP drugs, says biotech CEO after striking radiotherapy deal with AZ
More to come from PARP drugs, says biotech CEO after striking radiotherapy deal with AZ
Pharmaforum
AstraZeneca
Theragnostics
PARP inhibitors
diagnostics
cancer
Flag link:
Abbott Blood Test Can Detect Concussions that CT Scans Missed, Study Shows
Abbott Blood Test Can Detect Concussions that CT Scans Missed, Study Shows
BioSpace
diagnostics
Abbott Labs
concussions
Flag link:
Exagen Files for $57 Million IPO
Exagen Files for $57 Million IPO
CP Wire
Exagen
diagnostics
IPOs
Flag link:
Exagen Files for $57 Million IPO
Exagen
diagnostics
IPOs
Flag link:
AI Mines Clinical Data for Thyroid Cancer Therapeutic Targets
AI Mines Clinical Data for Thyroid Cancer Therapeutic Targets
Medical Devices and Diagnostics Industry
thyroid cancer
artificial intelligence
diagnostics
Predictive Oncology
Interpace Diagnostics
Flag link:
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Roche
viral assays
HIV
HPV
diagnostics
Global Access Program
Flag link:
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
Fierce Biotech
Guardant Health
biomarkers
diagnostics
DNA
cancer
solid tumors
Flag link:
Is a Low-Cost Blood Test for Alzheimer's on the Horizon?
Is a Low-Cost Blood Test for Alzheimer's on the Horizon?
BioSpace
diagnostics
Alzheimer's disease
Washington University
Flag link:
Vizai hopes Medtronic deal will boost sales of its tech – and vice versa
Vizai hopes Medtronic deal will boost sales of its tech – and vice versa
EP Vantage
devices
stroke
Medtronic
Vizai
artificial intelligence
diagnostics
Flag link:
First Two-Tiered Algorithm Snags FDA Clearance for Lyme Disease
First Two-Tiered Algorithm Snags FDA Clearance for Lyme Disease
RAPS.org
Lyme disease
diagnostics
FDA
Zeus
Flag link:
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
Flag link:

Pages